— Know what they know.
Not Investment Advice

IMAB NASDAQ

I-Mab
1W: +5.1% 1M: +8.2% 3M: +23.3% 1Y: +370.2% 3Y: +19.9% 5Y: -89.5%
$2.88
Last traded 2025-12-26 — delisted
NASDAQ · Healthcare · Biotechnology · $542.0M mcap · 82M float · 2.31% daily turnover · Short 36% of daily vol

Cash Flow Trends

Operating Cash Flow
-$53M +27.5% ▲
Capital Expenditures
$48K +70.7% ▲
5Y CAGR: -67.0%
Free Cash Flow
-$53M +27.6% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$335K +99.5% ▲
Net Change in Cash
-$242M +78.2% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income$471M-$2.3B-$2.5B-$207M-$50M
Depreciation & Amort.$23M$34M$64M$7M$978K
Stock-Based Comp.$493M$609M$357M$193M-$2M
Change in Working Capital-$241M$395M$552M-$37M-$3M
Other Non-Cash Items-$313M$321M$431M-$1.3B$809K
Operating Cash Flow$434M-$973M-$1.1B-$1.3B-$53M
— Investing Activities —
Capital Expenditures-$8M-$30M-$46M-$11M-$48K
Acquisitions (Net)-$258M-$6M$0$0$0
Investment Purchases-$2.5B-$10.2B-$7.4B$0-$246M
Investment Sales$2.5B$9.5B$7.9B$0$110M
Other Investing$52M$0$26K$114M$62K
Investing Cash Flow-$202M-$727M$458M$103M-$136M
— Financing Activities —
Net Debt Issuance-$8M$0$3M$10M$0
Stock Repurchased-$5M$0-$3M-$61M-$335K
Dividends Paid$0$0$0$0$0
Other Financing$2.9B$594M$61M$63M$0
Financing Cash Flow$3.4B$594M$42M$8M-$335K
Net Change in Cash$3.6B-$1.2B-$213M-$1.1B-$242M
Cash End of Period$4.8B$3.5B$3.3B$2.2B$498M
Free Cash Flow$426M-$1.0B-$1.1B-$73M-$53M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms